Samples for study ST002975
Species: BALB/C nude mice (Factor headings shown in green)
| mb_sample_id | Subject name | Sample name | Treatment | Sample_Data:RAW_FILE_NAME |
|---|---|---|---|---|
| SA323170 | - | 2A1-01-10381 | 5-fluorouracil | 2A1-01-10381.d |
| SA323172 | - | 2A1-02-10382 | 5-fluorouracil | 2A1-02-10382.d |
| SA323165 | - | 2A2-01-10383 | 5-fluorouracil | 2A2-01-10383.d |
| SA323164 | - | 2A2-02-10384 | 5-fluorouracil | 2A2-02-10384.d |
| SA323163 | - | 2B1-01-10385 | 5-fluorouracil | 2B1-01-10385.d |
| SA323166 | - | 2B1-02-10386 | 5-fluorouracil | 2B1-02-10386.d |
| SA323171 | - | 2B2-01-10387 | 5-fluorouracil | 2B2-01-10387.d |
| SA323167 | - | 2B2-02-10388 | 5-fluorouracil | 2B2-02-10388.d |
| SA323169 | - | 2B3-01-10389 | 5-fluorouracil | 2B3-01-10389.d |
| SA323168 | - | 2B3-02-10390 | 5-fluorouracil | 2B3-02-10390.d |
| SA323177 | - | 1A1-01-10368 | Doxorubicin | 1A1-01-10368.d |
| SA323176 | - | 1A1-02-10369 | Doxorubicin | 1A1-02-10369.d |
| SA323175 | - | 1A2-01-10370 | Doxorubicin | 1A2-01-10370.d |
| SA323173 | - | 1A2-02-10371 | Doxorubicin | 1A2-02-10371.d |
| SA323174 | - | 1A3-01-10372 | Doxorubicin | 1A3-01-10372.d |
| SA323179 | - | 1A3-02-10373 | Doxorubicin | 1A3-02-10373.d |
| SA323180 | - | 1B1-01-10374 | Doxorubicin | 1B1-01-10374.d |
| SA323184 | - | 1B1-02-10375 | Doxorubicin | 1B1-02-10375.d |
| SA323183 | - | 1B2-01-10376 | Doxorubicin | 1B2-01-10376.d |
| SA323182 | - | 1B2-02-10377 | Doxorubicin | 1B2-02-10377.d |
| SA323181 | - | 1B3-01-10378 | Doxorubicin | 1B3-01-10378.d |
| SA323178 | - | 1B3-02-10379 | Doxorubicin | 1B3-02-10379.d |
| SA323192 | - | 3A1-01-10392 | Doxorubicin + 5-fluorouracil | 3A1-01-10392.d |
| SA323191 | - | 3A1-02-10393 | Doxorubicin + 5-fluorouracil | 3A1-02-10393.d |
| SA323194 | - | 3A2-01-10394 | Doxorubicin + 5-fluorouracil | 3A2-01-10394.d |
| SA323193 | - | 3A2-02-10395 | Doxorubicin + 5-fluorouracil | 3A2-02-10395.d |
| SA323190 | - | 3B1-01-10396 | Doxorubicin + 5-fluorouracil | 3B1-01-10396.d |
| SA323186 | - | 3B1-02-10397 | Doxorubicin + 5-fluorouracil | 3B1-02-10397.d |
| SA323189 | - | 3B2-01-10398 | Doxorubicin + 5-fluorouracil | 3B2-01-10398.d |
| SA323185 | - | 3B2-02-10399 | Doxorubicin + 5-fluorouracil | 3B2-02-10399.d |
| SA323188 | - | 3B3-01-10400 | Doxorubicin + 5-fluorouracil | 3B3-01-10400.d |
| SA323187 | - | 3B3-02-10401 | Doxorubicin + 5-fluorouracil | 3B3-02-10401.d |
| SA323199 | - | 5A1-01-10416 | Negative Control | 5A1-01-10416.d |
| SA323204 | - | 5A1-02-10417 | Negative Control | 5A1-02-10417.d |
| SA323197 | - | 5A2-01-10418 | Negative Control | 5A2-01-10418.d |
| SA323196 | - | 5A2-02-10419 | Negative Control | 5A2-02-10419.d |
| SA323195 | - | 5A3-01-10420 | Negative Control | 5A3-01-10420.d |
| SA323198 | - | 5A3-02-10421 | Negative Control | 5A3-02-10421.d |
| SA323206 | - | 5B1-01-10422 | Negative Control | 5B1-01-10422.d |
| SA323205 | - | 5B1-02-10423 | Negative Control | 5B1-02-10423.d |
| SA323200 | - | 5B2-01-10424 | Negative Control | 5B2-01-10424.d |
| SA323203 | - | 5B2-02-10425 | Negative Control | 5B2-02-10425.d |
| SA323201 | - | 5B3-01-10426 | Negative Control | 5B3-01-10426.d |
| SA323202 | - | 5B3-02-10427 | Negative Control | 5B3-02-10427.d |
| SA323211 | - | 4A1-01-10403 | Positive Control | 4A1-01-10403.d |
| SA323210 | - | 4A1-02-10404 | Positive Control | 4A1-02-10404.d |
| SA323209 | - | 4A2-01-10405 | Positive Control | 4A2-01-10405.d |
| SA323208 | - | 4A2-02-10406 | Positive Control | 4A2-02-10406.d |
| SA323212 | - | 4A4-01-10407 | Positive Control | 4A4-01-10407.d |
| SA323213 | - | 4A4-02-10408 | Positive Control | 4A4-02-10408.d |
| SA323217 | - | 4B1-01-10409 | Positive Control | 4B1-01-10409.d |
| SA323216 | - | 4B1-02-10410 | Positive Control | 4B1-02-10410.d |
| SA323215 | - | 4B2-01-10411 | Positive Control | 4B2-01-10411.d |
| SA323214 | - | 4B2-02-10412 | Positive Control | 4B2-02-10412.d |
| SA323207 | - | 4B3-01-10413 | Positive Control | 4B3-01-10413.d |
| SA323218 | - | 4B3-02-10414 | Positive Control | 4B3-02-10414.d |
